2016 - Member of Academia Europaea
His primary areas of investigation include Immunology, Immune system, Dermatology, Psoriasis and Cancer research. His studies deal with areas such as Interleukin 12 and In vivo as well as Immunology. His Immune system study combines topics from a wide range of disciplines, such as Inflammation, Angiogenesis and Immunopathology.
The Vitiligo and PUVA therapy research he does as part of his general Dermatology study is frequently linked to other disciplines of science, such as Ultraviolet light and Localised scleroderma, therefore creating a link between diverse domains of science. His research in Psoriasis intersects with topics in Interleukin and STAT1. The Cancer research study combines topics in areas such as Interleukin 23 and Cell cycle.
His scientific interests lie mostly in Immunology, Dermatology, Immune system, Cancer research and Pathology. As part of his studies on Immunology, Martin Röcken often connects relevant areas like Cytotoxic T cell. His research in Immune system focuses on subjects like Inflammation, which are connected to Pharmacology.
The study incorporates disciplines such as Immune checkpoint, Senescence and Downregulation and upregulation in addition to Cancer research. His studies in Psoriasis integrate themes in fields like Multiple sclerosis and Atopic dermatitis. His Melanoma research includes elements of Internal medicine, Metastasis and Oncology.
His primary scientific interests are in Cancer research, Immune system, Melanoma, Immunotherapy and Immunology. Martin Röcken has researched Cancer research in several fields, including Immune checkpoint, Senescence, Downregulation and upregulation, Antigen and Lymphoma. His Immune system research is multidisciplinary, incorporating perspectives in Cancer, Cytokine and Pathology.
His work carried out in the field of Melanoma brings together such families of science as Internal medicine, Interquartile range, CDKN2A and Oncology. His work in Immunotherapy addresses subjects such as Cancer cell, which are connected to disciplines such as T cell. His study in the field of Adoptive cell transfer is also linked to topics like HLA-B27.
Immune system, Cancer research, Cancer, Immunotherapy and Immune checkpoint are his primary areas of study. His Immune system research focuses on Pathology and how it connects with Hypoxia, Ex vivo and Reactive oxygen species. His Cancer research research includes themes of Downregulation and upregulation, Antigen, Lymphatic system, MHC class I and Effector.
His biological study spans a wide range of topics, including Spleen, Red pulp, White pulp and Germinal center. As a part of the same scientific study, Martin Röcken usually deals with the Immunotherapy, concentrating on Cancer cell and frequently concerns with Melanoma. Martin Röcken has included themes like CTLA-4, CTL* and PD-L1 in his Immune checkpoint study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Simultaneous PET-MRI: a new approach for functional and morphological imaging
Martin S. Judenhofer;Hans F. Wehrl;Danny F. Newport;Ciprian Catana.
Nature Medicine (2008)
Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study
Kay D Brantsch;Christoph Meisner;Birgitt Schönfisch;Birgit Trilling.
Lancet Oncology (2008)
CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.
Stefan Zimmermann;Oliver Egeter;Susanne Hausmann;Grayson B. Lipford.
Journal of Immunology (1998)
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
M.K. Racke;A. Bonomo;D.E. Scott;B. Cannella.
Journal of Experimental Medicine (1994)
T-helper-1-cell cytokines drive cancer into senescence
Heidi Braumüller;Thomas Wieder;Ellen Brenner;Sonja Aßmann.
Angiogenesis drives psoriasis pathogenesis
Regina Heidenreich;Martin Röcken;Kamran Ghoreschi.
International Journal of Experimental Pathology (2009)
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Kamran Ghoreschi;Jürgen Brück;Christina Kellerer;Caishu Deng.
Journal of Experimental Medicine (2011)
TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.
Nele Müller-Hermelink;Heidi Braumüller;Bernd Pichler;Thomas Wieder.
Cancer Cell (2008)
DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.
Christian Adam;Susan King;Thomas Allgeier;Heidi Braumüller.
High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3
Dominic Francis De Nardo;Larisa I Labzin;Hajime Kono;Reiko Seki.
Nature Immunology (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: